PXL/HO/Cir-090/2025-26                                                                                           Date: 11.11.2025

Hyderabad

Subject: India–Ethiopia Pharmaceutical Cooperation in Regulatory, Procurement and Investment : Dates: 17 November 2025 – Mumbai | 19 November 2025 – Hyderabad

We are pleased to inform member companies that a High-Level Ministerial Delegation from Ethiopia, led by Hon’ble Mrs. Frehiwot Abebe, State Minister, Ministry of Health, Ethiopia, will be visiting India to strengthen bilateral cooperation in the pharmaceutical sector.

The Ethiopian delegation includes senior officials from the Ministry of Health, Ethiopian Food and Drugs Authority (EFDA), Ethiopian Pharmaceutical Procurement Services (EPPS), Ethiopian Investment Commission (EIC), and Industrial Parks Development Corporation (IPDC), among others.

Delegation Members:

• Mrs. Yewedealem Tesfaye, Advisor to Minister, Ministry of Health
• Ms. Heran Gerba, Director General, EFDA
• Dr. Abdulkedir Gelgelo, Director General, EPPS
• Mr. Aknaw Kawza, Deputy Director General, EPPS
• Mr. Zinabu Yirga, Deputy Commissioner, EIC
• Mr. Messay Woldemariam, Deputy Director General, AHRI
• Mr. Solomon Abdela Muktar, LoPID Forum, Ministry of Health
• Mr. Abdulkerim Karim, Chief Officer, IPDC
• Mr. Dawit Felleke, Advisor to Commissioner, EIC
• Mr. Wubshet Tadele, Deputy Director General, IPDC

Opportunities for Indian Pharmaceutical Companies:

India and Ethiopia share a robust and growing partnership in healthcare and pharmaceuticals. Ethiopia is actively seeking Indian investment and expertise in the following areas:

Pharmaceutical Manufacturing:Ethiopia has established GMP-compliant Special Economic Zones and offers incentives for setting up manufacturing units.

Regulatory Collaboration:Engagement with EFDA to align regulatory standards and fast-track approvals for Indian pharma products.

Public Procurement:Opportunities to supply essential medicines and medical devices through EPPS tenders.

R&D and Clinical Trials:Collaboration with institutions like AHRI for research partnerships.

Industrial Infrastructure:Access to plug-and-play facilities in Ethiopia’s industrial parks with tax and customs benefits.

Market Access:Ethiopia serves as a gateway to the African Continental Free Trade Area (AfCFTA), offering access to a broader regional market.

Meeting Schedule:

Mumbai: 17 November 2025 from 16:00-18:00 hrs at Orchid Hotel Mumbai

Hyderabad: 19 November 2025 from 9:30 to 12:00 noon- Venue(tbc)

These sessions will include regulatory briefings, procurement opportunities and investment discussions with Ethiopian officials.

Interested companies are requested to confirm their participation by filling the google form and register their participation: Register Here

We look forward to your active participation in this strategic engagement to deepen India–Ethiopia pharmaceutical collaboration.

With regards,

Raja Bhanu
Director General

Note: for more information

Mumbai – Mr. Rollins – 89206 10648

Hyderabad – Mr. Murali - 9849283461